NCT04583124View on ClinicalTrials.gov

Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

September 30, 2025

Conditions
Breast Neoplasm
Interventions
OTHER

ATENTO-B

Patients will perform therapeutic exercise and vagal activation techniques before medical treatment and will follow the usual care after medical treatment.

OTHER

ATENTO-T

Patients will perform therapeutic exercise and vagal activation techniques throughout medical treatment and will follow the usual care after medical treatment.

Trial Locations (1)

18016

RECRUITING

University of Granada, Granada

All Listed Sponsors
collaborator

Asociación Española contra el Cáncer

OTHER

lead

Universidad de Granada

OTHER